REGN vs SPIR
Regeneron Pharmaceuticals Inc (REGN) versus Spire Global Inc (SPIR) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Spire Global Inc (SPIR) is a specialty business services company listed on US.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Latest reported SPIR revenue for 2024-12-31 was $110.5M. Net income was -$102.8M. Revenue was up 13.2% from 2023-12-31 to 2024-12-31. SPIR currently screens at market cap $351.2M.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. SPIR currently screens at market cap $351.2M.
Not investment advice. Open the REGN and SPIR stock pages for the full models.
Not investment advice.